Tregs: Where We Are and What Comes Next?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

116 citing papers in PubMed.

1. T follicular regulatory cells suppress Tfh-mediated B cell help and synergistically increase IL-10-producing B cells in breast carcinoma.Immunologic research · 2019
   Trial
2. The Role of Chimeric Antigen Receptor Regulatory T Cells in Promoting Immune Tolerance in Solid Organ Transplantation:Saudi medical journal · 2026
   Review
3. The Therapeutic Potential of Farm Dust Extracts in a Mouse Model of Eosinophilic Inflammation.Allergy · 2026
   Article
4. A prognostic signature of ferroptosis and lipid metabolism related genes predicts survival and immunotherapy response in hepatocellular carcinoma.Discover oncology · 2026
   Article
5. Myeloid-derived suppressor cells and regulatory T cells in colorectal cancer: a synergistic immunosuppressive axis and emerging therapeutic opportunities.Frontiers in immunology · 2026
   Review
6. Type 1 diabetesNPJ autoimmunity · 2026
   Article
7. Beyond FoxP3-Identification of a Chicken Regulatory T Cell Signature.European journal of immunology · 2025
   Article
8. Dynamics of tissue repair regulatory T cells and damage in acute Trypanosoma cruzi infection.PLoS pathogens · 2025
   Article
9. Revisiting Tregs in cancer and beyond: immunological control and therapeutic potential.Frontiers in immunology · 2025
   Review
10. Induction of immune tolerance in NMOSD and MOGAD.Therapeutic advances in neurological disorders · 2025
    Review
11. Lung cancer immunotherapy in 2025: where we stand and what comes next?Frontiers in immunology · 2025
    Review
12. Treg cell plasticity as a driver of inflammation in spondyloarthritis and psoriasis.Frontiers in immunology · 2025
    Review
13. Expanding the horizon of CAR T cell therapy: from cancer treatment to autoimmune diseases and beyond.Frontiers in immunology · 2025
    Review
14. The Role of Exosomes in Cancer Progression and Therapy.Biology · 2025
    Review
15. CD4PeerJ · 2025
    Review
16. Recent advances in regulatory immune cells: exploring the world beyond Tregs.Frontiers in immunology · 2025
    Review
17. Revisiting the role of cancer-associated fibroblasts in tumor microenvironment.Frontiers in immunology · 2025
    Review
18. The clinical significance of T-cell regulation in hypertension treatment.Frontiers in immunology · 2025
    Review
19. The Role of Anesthetic Management in Lung Cancer Recurrence and Metastasis: A Comprehensive Review.Journal of clinical medicine · 2024
    Review
20. IL-33 Induces a Switch in Intestinal Metabolites Revealing the Tryptophan Pathway as a Target for Inducing Allograft Survival.Nutrients · 2024
    Article

56 more citing papers are in PubMed but not listed here.

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as